These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Pharmacological and Activated Fibroblast Targeting of Gβγ-GRK2 After Myocardial Ischemia Attenuates Heart Failure Progression. Travers JG; Kamal FA; Valiente-Alandi I; Nieman ML; Sargent MA; Lorenz JN; Molkentin JD; Blaxall BC J Am Coll Cardiol; 2017 Aug; 70(8):958-971. PubMed ID: 28818206 [TBL] [Abstract][Full Text] [Related]
25. Mdm2 regulates cardiac contractility by inhibiting GRK2-mediated desensitization of β-adrenergic receptor signaling. Jean-Charles PY; Yu SM; Abraham D; Kommaddi RP; Mao L; Strachan RT; Zhang ZS; Bowles DE; Brian L; Stiber JA; Jones SN; Koch WJ; Rockman HA; Shenoy SK JCI Insight; 2017 Sep; 2(17):. PubMed ID: 28878120 [TBL] [Abstract][Full Text] [Related]
26. G protein-coupled receptor kinase 2 contributes to impaired fatty acid metabolism in the failing heart. Pfleger J; Gross P; Johnson J; Carter RL; Gao E; Tilley DG; Houser SR; Koch WJ J Mol Cell Cardiol; 2018 Oct; 123():108-117. PubMed ID: 30171848 [TBL] [Abstract][Full Text] [Related]
27. GRK2 as a therapeutic target for heart failure. Cannavo A; Komici K; Bencivenga L; D'amico ML; Gambino G; Liccardo D; Ferrara N; Rengo G Expert Opin Ther Targets; 2018 Jan; 22(1):75-83. PubMed ID: 29166798 [TBL] [Abstract][Full Text] [Related]
28. G protein-coupled receptor kinase 2: a link between myocardial contractile function and cardiac metabolism. Woodall MC; Ciccarelli M; Woodall BP; Koch WJ Circ Res; 2014 May; 114(10):1661-70. PubMed ID: 24812353 [TBL] [Abstract][Full Text] [Related]
29. Adrenal beta-arrestin 1 inhibition in vivo attenuates post-myocardial infarction progression to heart failure and adverse remodeling via reduction of circulating aldosterone levels. Lymperopoulos A; Rengo G; Zincarelli C; Kim J; Koch WJ J Am Coll Cardiol; 2011 Jan; 57(3):356-65. PubMed ID: 21232674 [TBL] [Abstract][Full Text] [Related]
30. AAV6.βARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model. Raake PW; Schlegel P; Ksienzyk J; Reinkober J; Barthelmes J; Schinkel S; Pleger S; Mier W; Haberkorn U; Koch WJ; Katus HA; Most P; Müller OJ Eur Heart J; 2013 May; 34(19):1437-47. PubMed ID: 22261894 [TBL] [Abstract][Full Text] [Related]
31. Silencing nox4 in the paraventricular nucleus improves myocardial infarction-induced cardiac dysfunction by attenuating sympathoexcitation and periinfarct apoptosis. Infanger DW; Cao X; Butler SD; Burmeister MA; Zhou Y; Stupinski JA; Sharma RV; Davisson RL Circ Res; 2010 Jun; 106(11):1763-74. PubMed ID: 20413786 [TBL] [Abstract][Full Text] [Related]
32. Pharmacological inhibition of GRK2 improves cardiac metabolism and function in experimental heart failure. Ciccarelli M; Sorriento D; Fiordelisi A; Gambardella J; Franco A; Del Giudice C; Sala M; Monti MG; Bertamino A; Campiglia P; Oliveti M; Poggio P; Trinchese G; Cavaliere G; Cipolletta E; Mollica MP; Bonaduce D; Trimarco B; Iaccarino G ESC Heart Fail; 2020 Aug; 7(4):1571-1584. PubMed ID: 32352228 [TBL] [Abstract][Full Text] [Related]
33. Level of G protein-coupled receptor kinase-2 determines myocardial ischemia/reperfusion injury via pro- and anti-apoptotic mechanisms. Brinks H; Boucher M; Gao E; Chuprun JK; Pesant S; Raake PW; Huang ZM; Wang X; Qiu G; Gumpert A; Harris DM; Eckhart AD; Most P; Koch WJ Circ Res; 2010 Oct; 107(9):1140-9. PubMed ID: 20814022 [TBL] [Abstract][Full Text] [Related]
34. GRK2 in the heart: a GPCR kinase and beyond. Huang ZM; Gao E; Chuprun JK; Koch WJ Antioxid Redox Signal; 2014 Nov; 21(14):2032-43. PubMed ID: 24702056 [TBL] [Abstract][Full Text] [Related]
35. Overexpression of GRK2 in vascular smooth muscle leads to inappropriate hypertension and acute heart failure as in clinical scenario 1. Yano H; Onoue K; Tokinaga S; Ioka T; Ishihara S; Hashimoto Y; Nakada Y; Nakagawa H; Ueda T; Seno A; Nishida T; Watanabe M; Saito Y Sci Rep; 2023 May; 13(1):7707. PubMed ID: 37173348 [TBL] [Abstract][Full Text] [Related]
36. Impact of diabetes mellitus on lymphocyte GRK2 protein levels in patients with heart failure. Rengo G; Pagano G; Paolillo S; de Lucia C; Femminella GD; Liccardo D; Cannavo A; Formisano R; Petraglia L; Komici K; Rengo F; Trimarco B; Ferrara N; Leosco D; Perrone-Filardi P Eur J Clin Invest; 2015 Feb; 45(2):187-95. PubMed ID: 25545706 [TBL] [Abstract][Full Text] [Related]
38. Alpha2-adrenoceptors in adrenomedullary chromaffin cells: functional role and pathophysiological implications. Artalejo AR; Olivos-Oré LA Pflugers Arch; 2018 Jan; 470(1):61-66. PubMed ID: 28836008 [TBL] [Abstract][Full Text] [Related]
39. Regulation of cellular oxidative stress and apoptosis by G protein-coupled receptor kinase-2; The role of NADPH oxidase 4. Theccanat T; Philip JL; Razzaque AM; Ludmer N; Li J; Xu X; Akhter SA Cell Signal; 2016 Mar; 28(3):190-203. PubMed ID: 26631573 [TBL] [Abstract][Full Text] [Related]
40. Differential G protein receptor kinase 2 expression in compensated hypertrophy and heart failure after myocardial infarction in the rat. Theilade J; Strøm C; Christiansen T; Haunsø S; Sheikh SP Basic Res Cardiol; 2003 Mar; 98(2):97-103. PubMed ID: 12607131 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]